The Claim
In MUC1-overexpressing pancreatic cancer cells under glucose limitation, reprogramming of glutamine metabolism leads to aspartate accumulation and reduced pyrimidine nucleotide synthesis, resulting in G1 cell cycle arrest and decreased proliferation.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In pancreatic cancer cells with high levels of MUC1 protein and low glucose, changes in how glutamine is processed cause aspartate to build up and pyrimidine production to drop, which stops the cells from dividing.
See the scientific wording
In MUC1-overexpressing pancreatic cancer cells under glucose limitation, glutamine metabolism is reprogrammed to accumulate aspartate while reducing pyrimidine nucleotide synthesis, leading to G1 cell cycle arrest and reduced proliferation, suggesting a metabolic vulnerability specific to this cancer subtype.
When sugar is scarce, cancer cells with high levels of MUC1 protein pull in more glutamine and convert it into aspartate. Normally, aspartate would be used to build DNA components, but under low sugar, this process breaks down. Aspartate builds up instead, and DNA parts are not made. Without enough DNA parts, the cells cannot copy their DNA and get stuck before dividing, so they stop multiplying.
What the research says
1 studyStudy: Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
When sugar is low, pancreatic cancer cells with lots of MUC1 protein change how they use glutamine — instead of making DNA parts, they stockpile aspartate. This stops them from dividing and multiplying.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.